TARGETING DUAL CANCER-SPECIFIC ANTIGENS USING NOVEL IMMUNOTHERAPIES WITH A SAFE AND CONTROLLED IMMUNE BOOSTER FOR THE TREATMENT OF ADVANCED OVARIAN CANCER

Panorama Research Incorporated

Investigators